Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 32,082

Document Document Title
WO/2018/165501A1
The invention provides aryl indolinyl sulfonamide and related compounds, pharmaceutical compositions, methods of promoting RORĪ³ activity and/or increasing the amount of IL-17 in a subject, and therapeutic uses of the indolinyl sulfonami...  
WO/2018/164265A1
A compound represented by formula (1) provides an organic electroluminescent element that exhibits exceptional luminous efficiency. (In formula (1), R1-R8, R11-R18, R21, R22, L1, L2, L3, Ar1, and Ar2 are as defined in the description.)  
WO/2018/164545A1
The present invention provides a novel compound and an organic light emitting element using the same.  
WO/2018/160063A1
The invention is directed to the to the electrochemical preparation of 2,5- furandicarboxylic acid (FDCA) from 5-hydroxymethylfurfural (HMF) by electrochemical oxidation, comprising a first oxidation step of oxidizing HMF to 5-hydroxymet...  
WO/2018/157801A1
The present invention relates to a cyano group-substituted fused bicyclic derivative, and a pharmaceutical composition comprising the compound. The compound or the pharmaceutical composition can be used for inhibiting xanthine oxidase an...  
WO/2018/159650A1
The purpose of the present invention is to provide a compound which has a guanidine skeleton and inhibits the protease activity of MALT1 to exhibit a therapeutic effect or prophylactic effect on autoimmune diseases such as psoriasis. The...  
WO/2018/157981A1
The present invention relates to triarylamine compounds of general formula (I). The present invention further relates to methods for producing said compounds, oligomers, polymers or dendrimers and to formulations containing said compound...  
WO/2018/157604A1
A method for preparing an acidic and hydrophobic Pd/C catalytic material: sequentially carrying out modification by means of chlorosulfonic acid and trimethylchlorosilane, washing and drying, and then obtaining a modified Pd/C catalytic ...  
WO/2018/155340A1
The purpose of the present invention is to provide a liquid crystalline compound; a liquid crystal composition containing the compound; and a liquid crystal display element including the composition, the liquid crystalline compound satis...  
WO/2018/152949A1
The present invention relates to a method for preparing optically pure (R)-4-n-propyl-dihydrofuran-2(3H)-one, and belongs to the field of chemical synthesis. The method of the present invention uses the steps of alkylation, reduction, cy...  
WO/2018/153727A2
The present invention relates to a process for the carbonylation of allyl alcohols at low temperature, low pressure and/or low catalyst load. In an alternative embodiment, an acylation product of allyl alcohol is used for carbonylation. ...  
WO/2018/154519A1
The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compo...  
WO/2018/154493A1
The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compo...  
WO/2018/156443A1
Compounds of Formula I, or a pharmaceutically acceptable salt, solvate or hydrate thereof: (I). Also disclosed herein are uses of the compounds disclosed herein in the potential treatment or prevention of an IDO-associated disease or dis...  
WO/2018/151077A1
A compound represented by formula (1). In formula (1), at least one of R1-R10 is a group represented by formula (2). In formula (2), at least one of Ar1 and Ar2 is a group represented by formula (3).  
WO/2018/149850A1
The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic...  
WO/2018/149856A1
The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as tocompositions and ophthalmic ...  
WO/2018/150421A1
The invention provides efficient cyclization processes of hydroxyalkenoic acids and products produced therefrom. The following reactions are claimed: Formula (I), (II), (V) and (VI).  
WO/2018/149940A1
It is described an industrially viable and advantageous process for the preparation of (N- (((1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)methyl)p ropionamide, compound having the formula depicted below and generally known as Tasime...  
WO/2018/149853A1
The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic...  
WO/2018/149991A1
The present invention relates to particular sulfonamide derivatives, the pharmaceutically acceptable addition salts thereof, the hydrates thereof and/or the solvates thereof, and also the use thereof as inverse agonists of retinoid-relat...  
WO/2018/149852A1
The present invention relates to novel compounds (I) particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthal...  
WO/2018/147094A1
A compound represented by formula (I). (In formula (I), each of R1 and R2 independently represents a hydrogen atom or a methyl group; each of X1 and X2 independently represents a group that is represented by one of formula (X1-1) to form...  
WO/2018/146894A1
The problem addressed by this invention is to provide an organic electric field light-emitting element having optimal light-emitting characteristics. This problem is addressed by an organic electric field light-emitting element containin...  
WO/2018/146978A1
Provided is catalyst (for reduction reaction) which uses a raw material derived from biomass such that 1,4-butanediol or tetrahydrofuran can be obtained with a higher selectivity than is typical. This catalyst is used for a reduction rea...  
WO/2018/146122A1
The presently claimed invention is directed to a process for preparing D-glucaro-6,3-lactone from a salt of D-glucaric acid.  
WO/2018/145553A1
The present disclosure provides co-crystals of a substituted glycine compound and a co-former compound of Formula (I), compositions comprising such, and uses thereof in treating and/or reducing the risk for a neuropsychiatricdisorder (e....  
WO/2018/146962A1
The purpose of this invention is to provide an organic electric field light-emitting element having optimal light-emitting characteristics. This problem is solved by an organic electric field light-emitting element having a light-emittin...  
WO/2018/147373A1
A tetracarboxylic acid dianhydride which is composed of at least one acid dianhydride (A) selected from the group consisting of compounds having an endo/exo type steric structure represented by a specific general formula and enantiomers ...  
WO/2018/141706A1
The invention relates to propellane compounds according to defined formula, to the use of said compounds in electronic devices, and to electronic devices containing one or more of the known propellane compounds. The invention also relate...  
WO/2018/141854A1
The present invention provides piperazine derivatives exhibiting high affinity to the stem region (viral membrane proximal part) of influenza hemagglutinin as determined through competition binding and high virus neutralization activity ...  
WO/2018/144910A1
The disclosure provides a method of preventing or reducing protein aggregates using combretastatin-A4 (CA4) or an analog thereof. The disclosure also provides methods of reducing the risk, delaying the onset, delaying or slowing the prog...  
WO/2018/138359A1
The present invention provides novel compounds of formula (la) that are modulators of RORgamma. These compounds, and pharmaceutical compositions comprising the same, are suitable means for treating any disease wherein the modulation of R...  
WO/2018/137959A1
The present invention relates to a process for preparing benzylic amides of formula (I) wherein the variables have the meaning as defined in the description, by reductive amidation of a nitrile of formula (II) wherein the variables have ...  
WO/2018/140599A1
Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I) or a pharmaceutically acceptable salt, stereoisomer or prodrug thereof, wherein B, Z, Ra, Rb, Rc, R1, L, L1 ...  
WO/2018/139767A1
The present invention provides a novel amine-based compound and an organic light emitting device using the same.  
WO/2018/139787A1
The present invention relates to a method for purifying phenol, the method comprising the steps of: contacting a phenol stream, which contains hydroxy acetone, 2-methylbenzofuran, 3-methylbenzofuran, and phenol, with an acyl chloride, in...  
WO/2018/133790A1
The present disclosure relates to heteroaromatic containing organic compounds and methods of use and preparation thereof. The compounds disclosed herein can be used as organic semiconductors.  
WO/2018/133716A1
The present invention provides a heterocyclic urea compound as an indoleamine-2,3-dioxygenase inhibitor, a preparation method thereof, and a use of the heterocyclic urea compound as an indoleamine-2,3-dioxygenase inhibitor or a pharmaceu...  
WO/2018/135798A1
The present invention provides a novel heterocyclic compound and an organic light emitting element using the same.  
WO/2018/136792A1
The present disclosure provides compounds and methods for inhibiting or degrading the N-terminal domain of the androgen receptor, as well as methods for treating cancers such as prostate cancer.  
WO/2018/130625A1
The present invention relates to novel substituted benzene disulfonamides, as well as pharmaceutical compositions containing at least one of these substituted benzene disulfonamides together with at least one pharmaceutically acceptable ...  
WO/2018/132660A1
Disclosed herein are inhibitors of the Integrator complex, and methods for their use in treating or preventing diseases, such as cancer. The inhibitors described herein can include compounds of Formula (I) and pharmaceutically acceptable...  
WO/2018/130865A1
A composition for treating headaches and migraines and methods of using same for preventative use to decrease the frequency, duration and severity of headaches and migraines in children and adults.  
WO/2018/130155A1
Compounds serving as histone deacetylase 6 (HDAC6) selective inhibitors, and applications thereof in the preparation of drugs for treating HDAC6-related diseases. Specifically disclosed are a compound as represented by formula (I) and a ...  
WO/2018/122454A1
Ina method and an apparatus furfuralis recovered from a steam stream (3) which is formed in a treatment of a pretreated wood based material (1).The pretreated wood based material (1) which comprises at least carbohydrates is treated in a...  
WO/2018/121329A1
Disclosed are a magnetic metal oxide crosslinked acidic poly(ionic liquid) and the use thereof, wherein same belong to the technical field of solid acid catalysis. The catalyst prepared by the present invention has a good Lewis acidic si...  
WO/2018/124088A1
Provided are novel pest control agents, in particular, a bactericide and a nematicide. An alkylphenyl-substituted amide compound represented by formula (I) [wherein: G1 stands for a structure represented by G1-2, G1-3, G1-4, etc.; X1 sta...  
WO/2018/122453A1
In a method and an apparatus furfural is separated from a material stream (3) which is formed in a treatment of a pretreated wood based material (1). The material stream (3) which comprises at least furfural is introduced to a separation...  
WO/2018/115421A1
The present invention discloses compounds of formula (I) that are useful in the treatment of respiratory diseases of animals, especially Bovine or Swine Respiratory disease (BRD and SRD).  

Matches 1 - 50 out of 32,082